<?xml version="1.0" encoding="utf-8"?>
<oembed>
  <version>1</version>
  <type>rich</type>
  <provider_name>Libsyn</provider_name>
  <provider_url>https://www.libsyn.com</provider_url>
  <height>90</height>
  <width>600</width>
  <title>Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate Cancers</title>
  <description> Rick Greene, MD, discusses with Meghan R. Flanagan, MD, MPH, the results of a retrospective population-based study about genetic testing among patients with breast, ovarian, pancreatic and prostate cancers. Dr. Flanagan is author of, “Genetic Testing Among Patients with High-Risk Breast, Ovarian, Pancreatic, and Prostate Cancers.”  Dr. Flanagan is Assistant Professor of Surgery at the University of Washington School of Medicine, Seattle, WA.  http://doi.org/10.1245/S10434-022-12755-Y </description>
  <author_name>Speaking of SurgOnc</author_name>
  <author_url>https://www.surgonc.org/annals/speaking-of-surgonc/</author_url>
  <html>&lt;iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/25916763/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="90" width="600" scrolling="no"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen&gt;&lt;/iframe&gt;</html>
  <thumbnail_url>https://assets.libsyn.com/secure/item/25916763</thumbnail_url>
</oembed>
